Antioxidant and anticomplement activity of poly[3-(3,4-dihydroxyphenyl) glyceric acid] from Symphytum Asperum and Symphytum Caucasicum plants

Pharmaceutical Chemistry Journal

Volumn 41, Issue 1, 2007, Pages 14-16

  Barbakadze, V V ^a   Kemertelidze, E P ^a   Mulkijanyan, K G ^a   Van Den Berg, A J J ^b   Beukelman, C J ^b   Van Den Worm, E ^b   Quarles Van Ufford, H C ^b   Usov, A I ^c  

^a INSTITUTE OF PHYSICS   (Georgia)

^b UTRECHT UNIVERSITY   (Netherlands)

^c N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COMPLEMENT INHIBITOR; POLY[3 (3,4 DIHYDROXYPHENYL)GLYCERIC ACID]; POLYMER; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG ANALYSIS; DRUG MECHANISM; HUMAN; HUMAN CELL; MEDICINAL PLANT; NEUTROPHIL; NORMAL HUMAN; SYMPHYTUM ASPERUM; SYMPHYTUM CAUCASICUM; VASCULAR DISEASE; WOUND;

EID: 34548100898     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-007-0004-7     Document Type: Article

References (24)

1. M. B. Hampton, J. Kettle, and C. Winterbourn, Blood, 92, 3007-30017 (1998).
2. B. M. Babior, New Engl. J. Med, 298, 659-668 (1978).
3. B. M. Babior, Curr. Opin. Hematol., 2, 55-60 (1995).
4. S. J. Weiss, New Engl. J. Med, 320(6), 365-376 (1989).
5. H. L. Malech and J. I. Gallin, New Engl. J. Med, 317(11), 687-694 (1987).
6. B. Latha and M. Babu, Burns, 27, 309-317 (2001).
7. I. Roitt, J. Brostoff, and D. Male, in: Immunology: Complement (4th Ed.), Mosby, London (1996), Sects. 13.1-13.16.
8. V. V. Barbakadze, E. P. Kemertelidze, A. I. Usov, et al., Proc. Georgian Acad. Sci. Biol. Ser., 25(4-6), 207-216 (1999).
9. V. Barbakadze, E. Kemertelidze, I. Targamadze, et al., Trans-Caucasian J. Immunol, 1(2), 21-35 (1999).
10. V. V. Barbakadze, E. P. Kemertelidze, I. Targamadze, et al., Khim. Prir. Soedin., No. 4, 303-305 (2005).
11. V. V. Barbakadze, E. P. Kemertelidze, A. S. Shashkov, and A. I. Usov, Mendeleev Commun., 10(4), 148-149 (2000).
12. V. V. Barbakadze, E. P. Kemertelidze, I. Targamadze, et al., Bioorg. Khim., 28(4), 362-366 (2002) [Russ. J. Bioorg. Chem. (Engl. Transl.), 28(4), 326-330 (2002)].
13. D. Roos, A. A. M. Bot, M. L. J. van Schaik, et al., J. Immunol., 126(2), 433-440 (1981).
14. E. van denWorm, C. J. Beukelman, A. J. J. van den Berg, et al., Eur. J. Pharmacol., 433, 225-230 (2001).
15. J. P. A. M. Klerx, C. J. Beukelman, H. van Dijk, and H. J. M. N. Willers, J. Immunol. Methods., 63, 215-220 (1983).
16. J. M. Simons, L. A. 't Hart, H. van Dijk, et al., Ethnopharmacol, 26, 169-182 (1989).
17. H. A. Verbrugh, R. Peters, P. K. Peterson, and J. Verhoef, J. Clin. Pathol., 31, 539-545 (1978).
18. J. C. Whitin, D. H. Ryan, and H. J. Cohen, Blood, 66(5), 1182-1188 (1985).
19. N. Schnitzler, K. Schwezer, A. Podbielski, et al., Adv. Exp. Med. Biol., 418, 897-902 (1997).
20. C. Dahlgren, P. Follin, A. Jiohansson, et al., J. Biolum. Chemilum., 4, 263-266 (1989).
21. C. Dahlgren, H. Aniansson, and K. E. Magnusson, Infect. Immun., 47, 326-328 (1985).
22. J. M. McCord and I. Fridovich, J. Biol. Chem., 243(21), 5753-5760 (1968).
23. H. C. Chiang, Y. J. Lo, and F. J. Lu, J. Enzyme Inhib., 8(1), 61-71 (1994).
24. J. E. Chung, M. Kurisawa, Y-J. Kim, et al., Biomacromolecules, 5, 113-118 (2004).